1. Home
  2. NVAX vs HLMN Comparison

NVAX vs HLMN Comparison

Compare NVAX & HLMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVAX
  • HLMN
  • Stock Information
  • Founded
  • NVAX 1987
  • HLMN 1964
  • Country
  • NVAX United States
  • HLMN United States
  • Employees
  • NVAX N/A
  • HLMN N/A
  • Industry
  • NVAX Biotechnology: Biological Products (No Diagnostic Substances)
  • HLMN Industrial Machinery/Components
  • Sector
  • NVAX Health Care
  • HLMN Consumer Discretionary
  • Exchange
  • NVAX Nasdaq
  • HLMN Nasdaq
  • Market Cap
  • NVAX 2.0B
  • HLMN 2.1B
  • IPO Year
  • NVAX 1995
  • HLMN N/A
  • Fundamental
  • Price
  • NVAX $9.35
  • HLMN $10.82
  • Analyst Decision
  • NVAX Buy
  • HLMN Strong Buy
  • Analyst Count
  • NVAX 6
  • HLMN 6
  • Target Price
  • NVAX $17.83
  • HLMN $12.08
  • AVG Volume (30 Days)
  • NVAX 6.2M
  • HLMN 618.1K
  • Earning Date
  • NVAX 11-11-2024
  • HLMN 11-05-2024
  • Dividend Yield
  • NVAX N/A
  • HLMN N/A
  • EPS Growth
  • NVAX N/A
  • HLMN N/A
  • EPS
  • NVAX N/A
  • HLMN 0.03
  • Revenue
  • NVAX $987,667,000.00
  • HLMN $1,476,488,000.00
  • Revenue This Year
  • NVAX N/A
  • HLMN $1.39
  • Revenue Next Year
  • NVAX N/A
  • HLMN $4.61
  • P/E Ratio
  • NVAX N/A
  • HLMN $351.45
  • Revenue Growth
  • NVAX N/A
  • HLMN 1.20
  • 52 Week Low
  • NVAX $3.53
  • HLMN $6.02
  • 52 Week High
  • NVAX $23.86
  • HLMN $11.16
  • Technical
  • Relative Strength Index (RSI)
  • NVAX 32.54
  • HLMN 58.01
  • Support Level
  • NVAX $9.52
  • HLMN $10.59
  • Resistance Level
  • NVAX $10.63
  • HLMN $10.94
  • Average True Range (ATR)
  • NVAX 0.52
  • HLMN 0.27
  • MACD
  • NVAX -0.11
  • HLMN -0.00
  • Stochastic Oscillator
  • NVAX 1.68
  • HLMN 61.27

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. Novavax works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The Company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from Europe.

About HLMN Hillman Solutions Corp.

Hillman Solutions Corp is a provider of hardware-related products and related merchandising services to retail markets in North America. The company sells its products to hardware stores, home centers, mass merchants, pet supply stores, and other retail outlets. Its product lines include thousands of small parts such as fasteners and related hardware items; threaded rod and metal shapes; keys and accessories; builder's hardware; personal protective equipment, such as gloves and eye-wear; and identification items, such as tags and letters, numbers, and signs. The segments of the group are Hardware and Protective Solutions, which is the key revenue-generating segment; Robotics and Digital Solutions; and Canada. It has a business presence in the US, Canada and Mexico.

Share on Social Networks: